Welcome to Medications.com
 

Dusa Pharma Q4 Net Loss Narrows - RTT News

The company noted that the Non-PDT revenues were primarily driven by the sales of Nicomide which were adversely impacted by the residual levels of the ...

http://www.rttnews.com/sp/breakin... | Posted: Tue Mar 04 08:18:00 +0000 2008


© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea